Feasibility of Continuous Infusion of Cefiderocol in Conjunction with the Establishment of Therapeutic Drug Monitoring in Patients with Extensively Drug-Resistant Gram-Negative Bacteria
2023 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Feasibility of Continuous Infusion of Cefiderocol in Conjunction with the Establishment of Therapeutic Drug Monitoring in Patients with Extensively Drug-Resistant Gram-Negative Bacteria
Prinz, C.; Streit, F.; Schumann, C.; Dudakova, A.; Lanckohr, C.; Schanz, J. & Bohn, M. et al. (2023)
Clinical Drug Investigation, 43(4) pp. 307-314. DOI: https://doi.org/10.1007/s40261-023-01257-8
